Physician profile
Hannah E Lloyd
NPI 1730964594
$2,561.31
in general payments reported to CMS, 2019-2025
14 companies · $207 in 2025
The $207 reported for 2025 was more than what 81% of Advanced Practice Midwife providers received nationally (typical 2025 total: $70.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $2,354 · 2025: $207.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,506 · Travel and Lodging: $1,055.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,505.84 |
| Travel and Lodging | $1,055.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $1,774.34 | 2024 | Axonics |
| Sage Therapeutics, LLC | $185.38 | 2024-2025 | Zurzuvae |
| Inari Medical, INC. | $170.80 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Biogen, INC. | $107.96 | 2024 | Zurzuvae |
| Exeltis, USA INC. | $90.77 | 2024-2025 | Slynd |
| Bayer Healthcare Pharmaceuticals INC. | $41.93 | 2024 | |
| Hologic Sales and Service, LLC | $30.72 | 2025 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Sumitomo Pharma America, INC. | $28.93 | 2024 | Myfembree |
| Gynesonics, INC. | $25.46 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Agile Therapeutics, INC. | $23.29 | 2024 | Twirla |
| Organon LLC | $21.85 | 2025 | Nexplanon |
| Pfizer INC. | $21.19 | 2024 | |
| Mayne Pharma Commercial LLC | $20.78 | 2025 | |
| Evofem Biosciences, INC. | $17.91 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hannah Lloyd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.